Elsevier

The Lancet

Volume 389, Issue 10065, 14–20 January 2017, Page 156
The Lancet

Correspondence
Open letter on access to the BIA 10-2474 clinical trial data

https://doi.org/10.1016/S0140-6736(16)32515-6Get rights and content

References (4)

  • A Kerbrat et al.

    Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase

    N Engl J Med

    (2016)
  • S Bonini et al.

    First-in-human clinical trials—what we can learn from tragic failures

    N Engl J Med

    (2016)
There are more references available in the full text version of this article.

Cited by (9)

View all citing articles on Scopus
View full text